CHRISTIAN AGBISIT

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CHESAPEAKE, VA NPI 1306376488

General Payments — all program years on this page

$3,957.24

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 42
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,583.81 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,493.8220
Education $89.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $1,004.079
2023 $1,369.3612
2024 $1,583.8121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103179734 ABBVIE INC. $87.39 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104570996 AstraZeneca Pharmaceuticals LP $124.74 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104647873 AstraZeneca Pharmaceuticals LP $120.35 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113995087 Regeneron Healthcare Solutions, Inc. $124.45 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117489908 Amgen Inc. $106.03 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120851514 BeiGene USA, Inc. $92.62 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120851516 BeiGene USA, Inc. $125.00 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131690232 Legend Biotech USA Inc. $28.10 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136099742 Lilly USA, LLC $21.02 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136119107 Lilly USA, LLC $19.94 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139924341 GENZYME CORPORATION $43.44 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139924421 GENZYME CORPORATION $120.33 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141217896 Incyte Corporation $89.99 05/02/2024 Education Undisputed 01/23/2026 View at CMS
1141240363 Incyte Corporation $27.24 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142068788 Teleflex LLC $19.77 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142073004 Teleflex LLC $79.08 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142077221 Teleflex LLC $31.25 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144952125 Takeda Pharmaceuticals U.S.A., Inc. $29.08 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145198247 Rigel Pharmaceuticals, Inc. $24.37 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145208241 Rigel Pharmaceuticals, Inc. $126.50 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150209008 JAZZ PHARMACEUTICALS INC. $143.12 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.